Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Zhuming, Lu"'
Autor:
Shengshan Xu, Xiguang Chen, Haoxuan Ying, Jiarong Chen, Min Ye, Zhichao Lin, Xin Zhang, Tao Shen, Zumei Li, Youbin Zheng, Dongxi Zhang, Yongwen Ke, Zhuowen Chen, Zhuming Lu
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-21 (2024)
Abstract Purpose Lung adenocarcinoma (LUAD) significantly contributes to cancer-related mortality worldwide. The heterogeneity of the tumor immune microenvironment in LUAD results in varied prognoses and responses to immunotherapy among patients. Con
Externí odkaz:
https://doaj.org/article/eec514d656064bd681e30575ddb346de
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-20 (2024)
Abstract Purpose Recent studies have increasingly linked Ephrin receptor B2 (EPHB2) to cancer progression. However, comprehensive investigations into the immunological roles and prognostic significance of EPHB2 across various cancers remain lacking.
Externí odkaz:
https://doaj.org/article/daa24ebb74294bba9106ff8718c0b22b
Autor:
Shengshan Xu, Huiying Fang, Tao Shen, Yufu Zhou, Dongxi Zhang, Yongwen Ke, Zhuowen Chen, Zhuming Lu
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundPrevious studies have highlighted the crucial role of immune cells in lung cancer development; however, the direct link between immunophenotypes and lung cancer remains underexplored.MethodsWe applied two-sample Mendelian randomization (MR)
Externí odkaz:
https://doaj.org/article/b2008728142e402bb2e45c4d2fbf96b6
Autor:
Shengshan Xu, Xiguang Chen, Jianxiong Fang, Hongyu Chu, Shuo Fang, Leli Zeng, Hansu Ma, Tianzhi Zhang, Yu Chen, Tao Wang, Xin Zhang, Tao Shen, Youbin Zheng, Dongming Xu, Zhuming Lu, Yihang Pan, Yuchen Liu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundSolute carrier family 35 member A2 (SLC35A2), which belongs to the SLC35 solute carrier family of human nucleoside sugar transporters, has shown regulatory roles in various tumors and neoplasms. However, the function of SLC35A2 across human
Externí odkaz:
https://doaj.org/article/139b718ce62d4698be2a129c645bdd95
Autor:
Shengshan Xu, Yuchen Liu, Hansu Ma, Shuo Fang, Shoupeng Wei, Xiaoping Li, Zhuming Lu, Youbin Zheng, Tong Liu, Xiaojian Zhu, Dongming Xu, Yihang Pan
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Aberrant glycosylation is significantly related to the occurrence, progression, metastasis, and drug resistance of tumors. It is essential to identify glycosylation and related genes with prognostic value for breast cancer.Objective: We a
Externí odkaz:
https://doaj.org/article/80011c7030bf4c0bba160db5db1ea8ba
Autor:
Jiarong Chen, Aibin Liu, Zhihui Wang, Bin Wang, Xingxing Chai, Wenjie Lu, Ting Cao, Ronggang Li, Minyan Wu, Zhuming Lu, Wenguang Pang, Lin Xiao, Xiangmeng Chen, Yan Zheng, Qiong Chen, Jincheng Zeng, Jun Li, Xin Zhang, Dong Ren, Yanming Huang
Publikováno v:
Molecular Cancer, Vol 19, Iss 1, Pp 1-19 (2020)
Abstract Background Anti-angiogenic therapy represents a promising strategy for non-small-cell lung cancer (NSCLC) but its application in lung squamous cell carcinoma (SQC) is limited due to the high-risk adverse effects. Accumulating evidence indica
Externí odkaz:
https://doaj.org/article/bd0ab83dfd8f4d57a0e50a6fa980a82c
Autor:
Zhuming, Lu, Ming, Ye, Tao, Sun, Suoyun, Wu, Zhichao, Lin, Xin, Zhang, Dongping, Rao, Dongxi, Zhang, Yongwen, Ke, Zhuowen, Chen
Publikováno v:
Annals of Palliative Medicine. 11:2100-2109
The treatment of lung cancer patients, especially those with epidermal growth factor receptor (EGFR)-mutant T790M-negative adenocarcinoma, after first- or second-line tyrosine kinase inhibitor (TKI) treatment failure is challenging due to the poor pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52f9ac5947a073a7be335b42bb661957
https://doi.org/10.21037/apm-22-671
https://doi.org/10.21037/apm-22-671
Autor:
Wenhua, Liang, Kaican, Cai, Qingdong, Cao, Chun, Chen, Haiquan, Chen, Jun, Chen, Ke-Neng, Chen, Qixun, Chen, Tianqing, Chu, Yuchao, Dong, Jiang, Fan, Wentao, Fang, Junke, Fu, Xiangning, Fu, Shugeng, Gao, Di, Ge, Guojun, Geng, Qing, Geng, Jie, He, Jian, Hu, Jie, Hu, Wei-Dong, Hu, Feng, Jiang, Tao, Jiang, Wenjie, Jiao, He-Cheng, Li, Qiang, Li, Shanqing, Li, Shuben, Li, Xiangnan, Li, Yong-De, Liao, Changhong, Liu, Hongxu, Liu, Yang, Liu, Zhuming, Lu, Qingquan, Luo, Haitao, Ma, Xiaojie, Pan, Guibin, Qiao, Shengxiang, Ren, Weiyu, Shen, Yong, Song, Daqiang, Sun, Guangsuo, Wang, Jie, Wang, Mengzhao, Wang, Qiwen, Wang, Wen-Xiang, Wang, Li, Wei, Ming, Wu, Nan, Wu, Hui, Xia, Shi-Dong, Xu, Fan, Yang, Kang, Yang, Yue, Yang, Fenglei, Yu, Zhen-Tao, Yu, Dong-Sheng, Yue, Lanjun, Zhang, Weidong, Zhang, Zhenfa, Zhang, Guofang, Zhao, Jian, Zhao, Xiaojing, Zhao, Chengzhi, Zhou, Qinghua, Zhou, Kunshou, Zhu, Yuming, Zhu, Toyoaki, Hida, Wolfram C M, Dempke, Antonio, Rossi, Marc, de Perrot, Robert A, Ramirez, Mariano, Provencio, Jay M, Lee, Antonio, Passaro, Lorenzo, Spaggiari, Jonathan, Spicer, Nicolas, Girard, Patrick M, Forde, Tony S K, Mok, Tina, Cascone, Jianxing, He
Publikováno v:
Translational lung cancer research. 11(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba5053e4ca5d5dc5fb99963b8d4cc1c4
https://pubmed.ncbi.nlm.nih.gov/36248334
https://pubmed.ncbi.nlm.nih.gov/36248334
Autor:
Lin Xiao, Xiangmeng Chen, Jun Li, Minyan Wu, Xingxing Chai, Jincheng Zeng, Zhihui Wang, Dong Ren, Wenjie Lu, Aibin Liu, Ronggang Li, Ting Cao, Wenguang Pang, Qiong Chen, Yan Zheng, Chen Jiarong, Bin Wang, Zhuming Lu, Yanming Huang, Xin Zhang
Publikováno v:
Molecular Cancer
Molecular Cancer, Vol 19, Iss 1, Pp 1-19 (2020)
Molecular Cancer, Vol 19, Iss 1, Pp 1-19 (2020)
Background Anti-angiogenic therapy represents a promising strategy for non-small-cell lung cancer (NSCLC) but its application in lung squamous cell carcinoma (SQC) is limited due to the high-risk adverse effects. Accumulating evidence indicates that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5effc7d36c51b0fd84e49627194c6a01
https://doi.org/10.1186/s12943-020-01217-2
https://doi.org/10.1186/s12943-020-01217-2
Autor:
Jiarong Chen, Aibin Liu, Zhihui Wang, Wang, Bin, Xingxing Chai, Wenjie Lu, Cao, Ting, Ronggang Li, Minyan Wu, Zhuming Lu, Wenguang Pang, Xiao, Lin, Xiangmeng Chen, Zheng, Yan, Chen, Qiong, Jincheng Zeng, Li, Jun, Zhang, Xin, Ren, Dong, Yanming Huang
Additional file 8: Supplemental Table 1. The basic information of 20 NSCLC patients for LINC00173.v1 RT-qPCR analysis. Supplemental Table 2. The basic information of 43 patients with benign lung disease for LINC00173.v1 in situ hybridization analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d77dd89cbe749dd32fe40b4a577b16f
